Loading clinical trials...
Loading clinical trials...
This is a Phase 1, two-part, open-label study to evaluate the interaction of cyclosporine, probenecid, and rifampin as perpetrators with vadadustat (victim) in healthy male and female subjects.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Akebia Therapeutics
NCT05558150 · Drug Interaction Potentiation
NCT03886701 · Latent Tuberculosis, Human Immunodeficiency Virus, and more
NCT02191358 · Adverse Drug Events, Adverse Drug Reactions, and more
NCT02485028 · Drug Interaction Potentiation
NCT02485041 · Drug Interaction Potentiation
inVentiv Health Clinique Inc.
Québec, Quebec
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions